Indian Valacyclovir Exporters: Complete Supplier Ranking with Market Share — 197 Manufacturers (2026) — TransData Nexus

Q: Who is the largest valacyclovir buyer importing from India?

MYLAN PHARMACEUTICALS INC, (UNITED STATES) is the largest valacyclovir importer from India with a 22.0% market share and import value of $20.5M.

Q: How many valacyclovir buyers import from India?

There are 197 active valacyclovir buyers importing from India, with a combined import market of $93.2M across 2,537 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top valacyclovir buyers from India?

The top 5 valacyclovir buyers — MYLAN PHARMACEUTICALS INC,, MYLAN PHARMACEUTICALS INC, XXMBEXXPHAXXACEXXICAXX IXX, M/S. MYLAN PHARMACEUTICALS INC,, SIVEM PHARMACEUTICALS — together control 62.0% of total valacyclovir import value from India.

Suresh Sormare

Who Buys Valacyclovir from India — 197 Importers Behind a $93.2M Market

India's valacyclovir import market is served by 197 active buyers who collectively imported $93.2M across 2,537 shipments. MYLAN PHARMACEUTICALS INC, (UNITED STATES) leads with a 22.0% market share, followed by MYLAN PHARMACEUTICALS INC and XXMBEXXPHAXXACEXXICAXX IXX. The top 5 buyers together control 62.0% of total import value, reflecting a concentrated buyer landscape.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Top Valacyclovir Buyers & Importers — 197 buyers, $93.2M import market, top destinations and formulations — Valacyclovir buyer data — 197 importers · $93.2M market · 2,537 shipmentsTransData Nexus · Indian Customs Data

Top Valacyclovir Importers — Ranked by Import Value

MYLAN PHARMACEUTICALS INC, (UNITED STATES) is the leading valacyclovir importer from India, holding a 22.0% share of the $93.2M market across 2,537 shipments from 197 buyers. The top 5 buyers — MYLAN PHARMACEUTICALS INC, (UNITED STATES), MYLAN PHARMACEUTICALS INC (UNITED STATES), XXMBEXXPHAXXACEXXICAXX IXX (UNITED STATES), M/S. MYLAN PHARMACEUTICALS INC, (UNITED STATES), SIVEM PHARMACEUTICALS (UNITED STATES) — collectively control 62.0% of total import value.

Top Valacyclovir Buyers & Importers

Ranked by import value · 197 active buyers · Indian Customs (DGFT) data

Mar 2026

Top Valacyclovir Buyers & Importers — Ranked by Import Value. 197 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
#	Buyer & Formulations	Value	Orders	Suppliers	Share
1	MYLAN PHARMACEUTICALS INC,UNITED STATES VALACYCLOVIR TABLETVALACYCLOVIR TABLETS USP 1 GRAM C90 4988PACKSVALACYCLOVIR 1000MG TABLETS	$20.5M	23	5	22.0%
2	MYLAN PHARMACEUTICALS INCUNITED STATES VALACYCLOVIR TABLETVALACYCLOVIR TABLETS USP 1 GRAM C90 4988PACKSVALACYCLOVIR 1000MG TABLETS	$14.9M	21	5	16.0%
3	XXMBEXXPHAXXACEXXICAXX IXXUNITED STATES VALACYCLOVIR TABLETVALACYCLOVIR TABLETS USP 1 GRAM C90 4988PACKSVALACYCLOVIR 1000MG TABLETS	$9.3M	49	5	10.0%
4	M/S. MYLAN PHARMACEUTICALS INC,UNITED STATES	$6.6M	11	5	7.1%
5	SIVEM PHARMACEUTICALSUNITED STATES VALACYCLOVIR TABLETVALACYCLOVIR TABLETS USP 1 GRAM C90 4988PACKSVALACYCLOVIR 1000MG TABLETS	$6.5M	31	5	7.0%
6	CAMBER PHARMACEUTICALS INCUNITED STATES VALACYCLOVIR TABLETVALACYCLOVIR TABLETS USP 1 GRAM C90 4988PACKSVALACYCLOVIR 1000MG TABLETS	$2.9M	23	5	3.1%
7	CAMBER PHARMACEUTICALS INC.UNITED STATES VALACYCLOVIR TABLETVALACYCLOVIR TABLETS USP 1 GRAM C90 4988PACKSVALACYCLOVIR 1000MG TABLETS	$1.3M	7	5	1.4%
8	JAMP PHARMA CORPORATIONCANADA MYLAN VALACYCLOVIR 500 MG 100 BT TAB PACVALACICLOVIR TABLETS 500 MG 100'SMYLAN VALACYCLOVIR 500 MG 100 BT TAB PACKS 26657	$1.3M	37	5	1.4%
9	MYLAN PHARMACEUTICALS ULCCANADA VALACYCLOVIR TABLETVALACYCLOVIR TABLETS USP 1 GRAM C90 4988PACKSVALACYCLOVIR 1000MG TABLETS	$992.8K	4	5	1.1%
10	NORTHSTAR HEALTHCAREUNITED STATES VALACYCLOVIR TABLETVALACYCLOVIR TABLETS USP 1 GRAM C90 4988PACKSVALACYCLOVIR 1000MG TABLETS	$988.0K	6	5	1.1%
11	NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALSUNITED STATES VALACYCLOVIR TABLETVALACYCLOVIR TABLETS USP 1 GRAM C90 4988PACKSVALACYCLOVIR 1000MG TABLETS	$704.8K	3	5	0.8%
12	AURO PHARMA INCCANADA MYLAN VALACYCLOVIR 500 MG 100 BT TAB PACVALACICLOVIR TABLETS 500 MG 100'SMYLAN VALACYCLOVIR 500 MG 100 BT TAB PACKS 26657	$639.3K	3	5	0.7%
13	SAUDI AMAROX FOR INDUSTRY COMPANYSAUDI ARABIA HERPTREX VALACYCLOVIR 500MG TABLET 10SVALACYCLOVIR TABLETHERPTREX 500MG	$556.4K	7	5	0.6%
14	LLC SLS PHARMARUSSIA	$321.1K	8	5	0.3%
15	CIPLA USA INC UPS SUPPLY CHAIN SOLUUNITED STATES VALACYCLOVIR TABLETVALACYCLOVIR TABLETS USP 1 GRAM C90 4988PACKSVALACYCLOVIR 1000MG TABLETS	$318.3K	9	5	0.3%

Showing top 15 of 197 active valacyclovir buyers · Indian Customs (DGFT) · TransData Nexus

Related Analysis

Top Suppliers›HS Code Analysis›Network Analysis›

Need Details?

Get buyer profiles & contact data

Request Demo

Last updated: March 2026

Share:

Market Analysis: Top Importing Countries & Importers

Comprehensive geographic market intelligence dashboard

$93.2M

Market Value

2.5K

Total Shipments

5

Top Countries

$36.7K

Avg. Value

Complete Geographic Coverage (100%)

1United States

$81.2M87.2%

2Canada

$3.7M4.0%

3Taiwan

$3.0M3.3%

4Sweden

$1.9M2.0%

5Saudi Arabia

$611.4K0.7%

+Other Countries (65)

$2.7M2.9%

Geographic Coverage

100%

Complete market

87.2%

Top Country Share

Which companies are buying Valacyclovir — and from which countries?

Flow of Valacyclovir exports from India: each country's share and the named importers behind the numbers

Valacyclovir — Buyer Countries to Key Importers

Trade flow: top importing countries → named buyer companies

Top 5 importing countries account for 97.1% of global Valacyclovir imports — led by United States (87.2%) with a total trade value of $93.2M across 2,537 shipments from India.

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $81.2M through 189 shipments. This represents a market share of 87.2% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• MYLAN PHARMACEUTICALS INC, - $20.5M (25.3% of country's total business)

• MYLAN PHARMACEUTICALS INC - $14.9M (18.3% of country's total business)

• XXMBEXXPHAXXACEXXICAXX IXX - $9.3M (11.4% of country's total business)

• M/S. MYLAN PHARMACEUTICALS INC, - $6.6M (8.1% of country's total business)

• SIVEM PHARMACEUTICALS - $6.5M (8.0% of country's total business)

• Rest of United States's importers - $23.4M (28.9% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $429.8K, indicating premium pricing strategy compared to the market average of $36.7K.

United States is a key market for Valacyclovir imports, representing 87.2% of total trade value.

Primary Market

Secondary Market

2Canada

Canada emerges as the second largest importing country, achieving a total trade value of $3.7M through 44 shipments. This represents a market share of 4.0% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Canada has a diverse importer base, with their top importers including:

• JAMP PHARMA CORPORATION - $1.3M (35.7% of country's total business)

• MYLAN PHARMACEUTICALS ULC - $992.8K (26.9% of country's total business)

• AURO PHARMA INC - $639.3K (17.4% of country's total business)

Key Insight: Canada demonstrates strong market positioning with an average shipment value of $83.7K, indicating premium pricing strategy compared to the market average of $36.7K.

Canada is a key market for Valacyclovir imports, representing 4.0% of total trade value.

Primary Market

Secondary Market

3Taiwan

Taiwan emerges as the third largest importing country, achieving a total trade value of $3.0M through 0 shipments. This represents a market share of 3.3% of the total market activity, demonstrating their significant presence in the industry.

Key Insight: Taiwan demonstrates strong market positioning with an average shipment value of $3.0M, indicating premium pricing strategy compared to the market average of $36.7K.

Taiwan is a key market for Valacyclovir imports, representing 3.3% of total trade value.

Primary Market

Secondary Market

4Sweden

Sweden emerges as the fourth largest importing country, achieving a total trade value of $1.9M through 0 shipments. This represents a market share of 2.0% of the total market activity, demonstrating their significant presence in the industry.

Key Insight: Sweden demonstrates strong market positioning with an average shipment value of $1.9M, indicating premium pricing strategy compared to the market average of $36.7K.

Sweden is a key market for Valacyclovir imports, representing 2.0% of total trade value.

Primary Market

Secondary Market

5Saudi Arabia

Saudi Arabia emerges as the fifth largest importing country, achieving a total trade value of $611.4K through 7 shipments. This represents a market share of 0.7% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Saudi Arabia has a diverse importer base, with their top importers including:

• SAUDI AMAROX FOR INDUSTRY COMPANY - $556.4K (91.0% of country's total business)

Key Insight: Saudi Arabia demonstrates strong market positioning with an average shipment value of $87.3K, indicating premium pricing strategy compared to the market average of $36.7K.

Saudi Arabia is a key market for Valacyclovir imports, representing 0.7% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Valacyclovir buyer market intelligence

1Buyer Segment Analysis

The primary buyers of Valacyclovir imported from India can be categorized into the following segments:

1. Pharmaceutical Companies: Entities like MYLAN PHARMACEUTICALS INC and CAMBER PHARMACEUTICALS INC, both based in the United States, fall into this category. These companies typically engage in large-volume purchases to supply their extensive distribution networks, ensuring consistent availability of Valacyclovir across various markets.

2. Distributors: Companies such as SIVEM PHARMACEUTICALS in the United States and JAMP PHARMA CORPORATION in Canada act as intermediaries, purchasing Valacyclovir in bulk from Indian exporters and distributing it to pharmacies, hospitals, and other healthcare providers. Their buying behavior is characterized by regular, sizable orders to maintain a steady supply chain.

3. Contract Manufacturers: Entities like MYLAN PHARMACEUTICALS ULC in Canada may also function as contract manufacturers, producing Valacyclovir for other brands or companies. Their procurement patterns are aligned with production schedules and contractual obligations, leading to periodic bulk purchases.

Each segment's purchasing behavior reflects their role in the pharmaceutical supply chain, with a focus on maintaining inventory levels to meet market demand and regulatory requirements.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Valacyclovir buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Valacyclovir from India, the import regulations are as follows:

1. United States:

Drug Regulatory Authority: Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Valacyclovir is FDA-approved and complies with the Federal Food, Drug, and Cosmetic Act. The FDA's "Safe Importation Action Plan" allows for the importation of certain prescription drugs from Canada under specific programs.

Estimated Timeline for Registration: The timeline varies based on the specific importation program and compliance with FDA requirements.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in the United States.

2. Canada:

Drug Regulatory Authority: Health Canada.

Import Registration Process: Valacyclovir must be authorized by Health Canada. In cases of drug shortages, Health Canada maintains a list of drugs eligible for exceptional importation and sale. (canada.ca)

Estimated Timeline for Registration: Standard registration can take several months; however, the exceptional importation process is expedited during shortages.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically duty-free in Canada.

3. Taiwan:

Drug Regulatory Authority: Taiwan Food and Drug Administration (TFDA).

Import Registration Process: Importers must obtain approval from the TFDA, ensuring compliance with local pharmaceutical regulations.

Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and compliance with TFDA requirements.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally subject to low or zero tariffs in Taiwan.

4. Sweden:

Drug Regulatory Authority: Swedish Medical Products Agency (MPA).

Import Registration Process: Valacyclovir must be approved by the MPA, adhering to the European Medicines Agency (EMA) guidelines.

Estimated Timeline for Registration: The process typically takes several months, contingent on EMA's centralized procedures and MPA's national requirements.

Import Tariff/Duty for HS 30049099: As a member of the European Union, Sweden applies the EU's Common External Tariff, which is generally low or zero for pharmaceutical products.

5. Saudi Arabia:

Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA).

Import Registration Process: Importers must register Valacyclovir with the SFDA, ensuring compliance with local pharmaceutical standards and regulations.

Estimated Timeline for Registration: The registration process can take several months, depending on the SFDA's review and approval procedures.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically exempt from import duties in Saudi Arabia.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Demand Drivers & Market Opportunity

TransData Nexus Valacyclovir buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Valacyclovir in importing countries is primarily driven by the prevalence of herpes simplex virus (HSV) infections, including genital herpes and cold sores, as well as herpes zoster (shingles). According to the World Health Organization (WHO), in 2022, an estimated 3.7 billion people under age 50 (67%) had HSV-1 infection globally, and 491 million people aged 15–49 (13%) had HSV-2 infection. This substantial prevalence underscores the consistent need for antiviral treatments like Valacyclovir.

Government healthcare programs and the expansion of universal health coverage also contribute significantly to the demand. Many countries include Valacyclovir in their national essential medicines lists, aligning with the WHO Model List of Essential Medicines, which recommends the availability of essential medicines at all times in adequate amounts. Additionally, tender-based purchasing by government agencies and international organizations ensures a steady procurement of Valacyclovir to meet public health needs. The presence of 197 buyers across 70 countries, as per TransData Nexus data, indicates a broad and sustained market opportunity for Valacyclovir exports from India.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Valacyclovir Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest valacyclovir buyer importing from India?

Based on import volume and value, MYLAN PHARMACEUTICALS INC, (UNITED STATES) leads with $20.5M in imports and a 22.0% market share — the highest of any single valacyclovir importer. MYLAN PHARMACEUTICALS INC (UNITED STATES) and XXMBEXXPHAXXACEXXICAXX IXX (UNITED STATES) are the next largest buyers.

QHow many companies buy valacyclovir from India?

There are 197 active valacyclovir buyers importing from India, with a combined market of $93.2M across 2,537 shipments to 70 countries. The top 5 buyers hold 62.0% of total import value, while the remaining 192 buyers handle the other 38.0%.

QWhich countries import the most valacyclovir from India?

The top importing countries for valacyclovir from India are United States (87.2%), Canada (4.0%), Taiwan (3.3%), Sweden (2.0%), Saudi Arabia (0.7%). These markets represent the largest demand centres for Indian pharmaceutical exports of valacyclovir, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for valacyclovir from India?

The average import transaction value for valacyclovir from India is $36.7K, with an average unit price of $3.32 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Valacyclovir buyer market intelligence

1Buyer Segment Analysis

The primary buyers of Valacyclovir imported from India can be categorized into the following segments:

1. Pharmaceutical Companies: Entities like MYLAN PHARMACEUTICALS INC and CAMBER PHARMACEUTICALS INC, both based in the United States, fall into this category. These companies typically engage in large-volume purchases to supply their extensive distribution networks, ensuring consistent availability of Valacyclovir across various markets.

2. Distributors: Companies such as SIVEM PHARMACEUTICALS in the United States and JAMP PHARMA CORPORATION in Canada act as intermediaries, purchasing Valacyclovir in bulk from Indian exporters and distributing it to pharmacies, hospitals, and other healthcare providers. Their buying behavior is characterized by regular, sizable orders to maintain a steady supply chain.

3. Contract Manufacturers: Entities like MYLAN PHARMACEUTICALS ULC in Canada may also function as contract manufacturers, producing Valacyclovir for other brands or companies. Their procurement patterns are aligned with production schedules and contractual obligations, leading to periodic bulk purchases.

Each segment's purchasing behavior reflects their role in the pharmaceutical supply chain, with a focus on maintaining inventory levels to meet market demand and regulatory requirements.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Valacyclovir buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Valacyclovir from India, the import regulations are as follows:

1. United States:

Drug Regulatory Authority: Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Valacyclovir is FDA-approved and complies with the Federal Food, Drug, and Cosmetic Act. The FDA's "Safe Importation Action Plan" allows for the importation of certain prescription drugs from Canada under specific programs.

Estimated Timeline for Registration: The timeline varies based on the specific importation program and compliance with FDA requirements.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in the United States.

2. Canada:

Drug Regulatory Authority: Health Canada.

Import Registration Process: Valacyclovir must be authorized by Health Canada. In cases of drug shortages, Health Canada maintains a list of drugs eligible for exceptional importation and sale. (canada.ca)

Estimated Timeline for Registration: Standard registration can take several months; however, the exceptional importation process is expedited during shortages.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically duty-free in Canada.

3. Taiwan:

Drug Regulatory Authority: Taiwan Food and Drug Administration (TFDA).

Import Registration Process: Importers must obtain approval from the TFDA, ensuring compliance with local pharmaceutical regulations.

Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and compliance with TFDA requirements.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally subject to low or zero tariffs in Taiwan.

4. Sweden:

Drug Regulatory Authority: Swedish Medical Products Agency (MPA).

Import Registration Process: Valacyclovir must be approved by the MPA, adhering to the European Medicines Agency (EMA) guidelines.

Estimated Timeline for Registration: The process typically takes several months, contingent on EMA's centralized procedures and MPA's national requirements.

Import Tariff/Duty for HS 30049099: As a member of the European Union, Sweden applies the EU's Common External Tariff, which is generally low or zero for pharmaceutical products.

5. Saudi Arabia:

Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA).

Import Registration Process: Importers must register Valacyclovir with the SFDA, ensuring compliance with local pharmaceutical standards and regulations.

Estimated Timeline for Registration: The registration process can take several months, depending on the SFDA's review and approval procedures.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically exempt from import duties in Saudi Arabia.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Demand Drivers & Market Opportunity

TransData Nexus Valacyclovir buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Valacyclovir in importing countries is primarily driven by the prevalence of herpes simplex virus (HSV) infections, including genital herpes and cold sores, as well as herpes zoster (shingles). According to the World Health Organization (WHO), in 2022, an estimated 3.7 billion people under age 50 (67%) had HSV-1 infection globally, and 491 million people aged 15–49 (13%) had HSV-2 infection. This substantial prevalence underscores the consistent need for antiviral treatments like Valacyclovir.

Government healthcare programs and the expansion of universal health coverage also contribute significantly to the demand. Many countries include Valacyclovir in their national essential medicines lists, aligning with the WHO Model List of Essential Medicines, which recommends the availability of essential medicines at all times in adequate amounts. Additionally, tender-based purchasing by government agencies and international organizations ensures a steady procurement of Valacyclovir to meet public health needs. The presence of 197 buyers across 70 countries, as per TransData Nexus data, indicates a broad and sustained market opportunity for Valacyclovir exports from India.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the official agencies above.

Research Methodology & Data Transparency

SS

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Identification: 197 global importers of Valacyclovir identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 2,537 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 70 destination countries with market share per buyer calculated from capped values.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,537 Verified Shipments

197 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists